The relationship between systemic inflammatory markers and lipoprotein size is not well documented; a high concentration of small dense LDL is often concomitant with elevated inflammatory marker concentration in patients with metabolic syndrome and type II diabetes [24]–[26] However, lipoprotein size and subclasses' concentration were not associated with the inflammatory markers hsCRP and IL-6 measured in this study, as previously shown in HIV-infected patients [27]. This evidence concerns the gene IL6 and metabolic syndrome.